Últimos Artículos de Terapeuthic Advances in Endocrinology and Metabolism

- Comment on “the effect of concurrent exercise training (resistance and interval running) and mindful self-compassion therapy on heart rate variability in type 1 diabetes”
- Efficacy and safety of denosumab administered at 6-monthly versus 9-monthly intervals in postmenopausal osteoporosis: Protocol for a randomized, open-label, blinded endpoint clinical trial
- Semaglutide and cardio-renal protection: Mechanistic insights from FLOW, SELECT and the NHE3 paradox
- Heterogeneous TRAb trajectories after total thyroidectomy in graves’ disease with thyroid eye disease
- Analysis of composite immune-inflam matory indices using interpretable machine learning for identifying prevalent metabolic dysfunction-associated steatotic liver disease in patients with diabetes
- TRAb-negative euthyroid thyroid eye disease: A case report and literature review
- Oxidative stress in diabetic peripheral neuropathies: Key mechanisms and therapeutic targets
- A rare presentation of RET mutation: Early-onset medullary thyroid carcinoma with intestinal neuronal dysplasia and chronic kidney disease, A case report and literature review
- Perceptions of mobile applications and websites for diabetes management among adults with type 2 diabetes in Jordan: A qualitative study
- Metabolic syndrome and hormonal correlates of its predominant components among postmenopausal women: An institution-based cross-sectional study
- Cardiovascular promise requires endpoint discipline: interpreting tirzepatide after SURPASS-CVOT
- Erratum to “Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing’s syndrome”
- Serum testosterone and uric acid: Key biomarkers for predicting response to drospirenone/ethinyl estradiol tablets (II) in adolescents polycystic ovary syndrome
- Author’s reply to the letter to the editor by Yongzhang Qin and Shihua Hong, “Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing’s syndrome”
- Impact of training type (virtual vs in-person) on long-term glycemic control in people with type 1 diabetes using minimed 780: A non-inferiority longitudinal study
- Metabolic effects of GLP-1 and GLP-2 across fed, fasting, and starvation states: A systematic review with structured narrative synthesis
- Systematic review and network meta-analysis of the safety and efficacy of the triple incretin receptor agonist, retatrutide compared to the dual incretin receptor agonist, tirzepatide, for treatment of type 2 diabetes mellitus
- The uric acid-to-homocysteine ratio as a prognostic marker for all-cause and cardiovascular mortality: A national population-based study
- Associations of mortality and sepsis after GLP-1 receptor agonist initiation versus SGLT2 inhibitor or metformin initiation in people with HIV, overweight or obesity, and type 2 diabetes: A target trial emulation
- Dietary protein content and its impact on amino acid profile and appetite in patients with methylmalonic acidemia